Global Kidney Transplantation Clinical Trials Review 2013: Worldwide Industry Share, Investment Trends, Growth, Size, Strategy And Forecast Research Report 2013
Albany, NY (PRWEB) December 11, 2013 -- Kidney Transplantation Global Clinical Trials Review, H2, 2013
Clinical trial report, "Kidney Transplantation Global Clinical Trials Review, H2, 2013" provides data on the Kidney Transplantation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Kidney Transplantation. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Kidney Transplantation. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/kidney-transplantation-global-clinical-trials-review-h2-2013.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/sample/180516
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Kidney Transplantation 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Kidney Transplantation 23
Subjects Recruited Over a Period of Time 33
Prominent Sponsors 34
Top Companies Participating in Kidney Transplantation Therapeutics Clinical Trials 36
Prominent Drug Comparison 38
Clinical Trial Profiles 39
Clinical Trial Overview of Top Companies 39
Novartis AG 39
Clinical Trial Overview of Novartis AG 39
Astellas Pharma Inc. 55
Clinical Trial Overview of Astellas Pharma Inc. 55
F. Hoffmann-La Roche Ltd. 61
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 61
Pfizer Inc. 66
Clinical Trial Overview of Pfizer Inc. 66
Sanofi 70
Clinical Trial Overview of Sanofi 70
Bristol-Myers Squibb Company 72
Clinical Trial Overview of Bristol-Myers Squibb Company 72
Mayo Clinic 74
Clinical Trial Overview of Mayo Clinic 74
Alexion Pharmaceuticals, Inc. 76
Clinical Trial Overview of Alexion Pharmaceuticals, Inc. 76
Veloxis Pharmaceuticals A/S 77
Clinical Trial Overview of Veloxis Pharmaceuticals A/S 77
Amgen Inc. 78
Clinical Trial Overview of Amgen Inc. 78
Clinical Trial Overview of Top Institutes / Government 79
The National Institute of Allergy and Infectious Diseases 79
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 79
University of Cincinnati 81
Clinical Trial Overview of University of Cincinnati 81
University of Miami 82
Clinical Trial Overview of University of Miami 82
Northwestern University 83
Clinical Trial Overview of Northwestern University 83
University of Wisconsin Madison 84
Clinical Trial Overview of University of Wisconsin Madison 84
The National Institute of Diabetes and Digestive and Kidney Diseases 85
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 85
Medical University of Vienna 86
Clinical Trial Overview of Medical University of Vienna 86
Erasmus MC 87
Clinical Trial Overview of Erasmus MC 87
Emory University 88
Clinical Trial Overview of Emory University 88
University of Minnesota 89
Clinical Trial Overview of University of Minnesota 89
Five Key Clinical Profiles 90
Appendix 151
Abbreviations 151
Definitions 151
Research Methodology 153
Secondary Research 153
About GlobalData 154
Contact Us 154
Disclaimer 154
Source 155 List of Tables
Kidney Transplantation Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7
Kidney Transplantation Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Kidney Transplantation Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Kidney Transplantation Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 10
Kidney Transplantation Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11
Kidney Transplantation Therapeutics Clinical Trials, North America, Top Countries, 2013* 12
Kidney Transplantation Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 13
Kidney Transplantation Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 14
Kidney Transplantation Therapeutics Clinical Trials, BRIC Countries, 2013* 15
Kidney Transplantation Therapeutics Clinical Trials, G7 Countries, 2013* 16
Kidney Transplantation Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Kidney Transplantation Therapeutics Clinical Trials, E7 Countries, 2013* 18
Kidney Transplantation Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Kidney Transplantation Therapeutics Market, Global, Clinical Trials by Phase, 2013* 20
Kidney Transplantation Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 21
Kidney Transplantation Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Kidney Transplantation Therapeutics Market, Global, Suspended Clinical Trials, 2013* 23
Kidney Transplantation Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 24
Kidney Transplantation Therapeutics Market, Global, Terminated Clinical Trials, 2013* 25
Kidney Transplantation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 33
Kidney Transplantation Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 35
Kidney Transplantation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 37
Kidney Transplantation Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 38
Kidney Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 39
Kidney Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2013* 55
Kidney Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2013* 61
Kidney Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 66
Kidney Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 70
Kidney Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2013* 72
Kidney Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2013* 74
Kidney Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by Alexion Pharmaceuticals, Inc., 2013* 76
Kidney Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by Veloxis Pharmaceuticals A/S, 2013* 77
Kidney Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2013* 78
Kidney Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2013* 79
Kidney Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cincinnati, 2013* 81
Kidney Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2013* 82
Kidney Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2013* 83
Kidney Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2013* 84
Kidney Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2013* 85
Kidney Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2013* 86
Kidney Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2013* 87
To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/180516
Kidney Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2013* 88
Kidney Transplantation Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2013* 89 List of Figures
Kidney Transplantation Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7
Kidney Transplantation Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Kidney Transplantation Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Kidney Transplantation Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 10
Kidney Transplantation Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11
Kidney Transplantation Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12
Kidney Transplantation Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 13
Kidney Transplantation Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 14
Kidney Transplantation Therapeutics Clinical Trials, BRIC Countries (%), 2013* 15
Kidney Transplantation Therapeutics Clinical Trials, G7 Countries (%), 2013* 16
Kidney Transplantation Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Kidney Transplantation Therapeutics Clinical Trials, E7 Countries (%), 2013* 18
Kidney Transplantation Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Kidney Transplantation Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 20
Kidney Transplantation Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 21
Kidney Transplantation Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Kidney Transplantation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 33
Kidney Transplantation Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 34
Kidney Transplantation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 36
Kidney Transplantation Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 38
GlobalData Methodology 153
Latest Reports:
Collagen and (Hyaluronic Acid) HA-Based Biomaterials Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis-details/collagen-and-hyaluronic-acid-ha-based-biomaterials-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019.
Biomaterials are referred to as natural or synthetic materials intended to use in several applications such as prosthetics, therapeutic, diagnostic and storage applications. These materials come in contact with various elements of biological systems such as biological fluids and various tissues. These materials can either be obtained from nature or synthesized in the laboratory with help of various chemical synthesis procedures. Based on the nature of the biomaterials there are three types of biomaterials used namely, naturally derived materials, semi-synthetic or hybrid and synthetic biomaterials.
Metals, polymers, ceramics and composites are some of the examples of synthetic biomaterials and natural biomaterials that comprises animal or plant derived biomaterials such as various proteins (collagen, elastinand others). Collagen is one of the most abundant form of proteins present in the human body, use of these biomaterials in the tissue engineering have increased extensively. This is attributed by its features such as biodegradability, easy availability, versatility and biocompatibility. Hyaluronic acid (HA) is referred to as a natural substance present in body fluids, highest concentration being in eye and joint fluids. The U.S. FDA has approved the use of HA during certain surgical procedures such as cataract removal, eye surgery, corneal transplantation and others.
Collagen and HA based biomaterials have potential applications in the field of regenerative medicine, personal healthcare, development of prosthetics and various aesthetic procedures. The collagen and HA based biomaterials market can be segmented based on product type, applications and geography. Collagen biomaterials comprise urinary incontinence implants, stress incontinence, collagen corneal shields and others. Facial dermal fillers, HA soft tissue fillers and HA based viscosupplements are some of the HA based biomaterials. The geographic segmentation comprises of four major regions namely, North America, Europe, Asia-Pacific and RoW.
Some of the major factors encouraging market growth constitutes the constant rise in geriatric population, increased preference for personal healthcare, continuous technological upgradations followed by heightened demand for anti-aging treatments. Working women and baby boomers constitutes prime target population of this market.
Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/toc/175980
The increasing incidences of osteoarthritis across the globe further boost the uptake of these biomaterials. However, restricted supply of biomaterials and increasing threat of substitutes are some of the factors which might hamper the growth of the market. The key players competing in this market are Sanofi, Genzyme, Inc., Bausch & Lomb, Advanced Medical Optics and Life Core Biomedical, LLC.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
• North America
• Asia Pacific
• Europe
• Rest of the World
This report provides comprehensive analysis of
• Market growth drivers
• Factors limiting market growth
• Current market trends
• Market structure
• Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Dimethyl Ether Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis-details/dimethyl-ether-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019.
Dimethyl Ether is clean, liquefied, colourless gas produced by dehydration of methanol. Dimethyl Ether is also called as wood ether or methyl ether. It exhibit properties similar to liquid petroleum gas (LPG) or natural gas (NG), and hence can be used as an alternative for fire and transportation fuel. It is also used as propellant in consumer products which include domains such as household products, personal health care products (hairspray,foam shaving cream, antiperspirant, etc.), insect control and various other applications.
DME production as well as consumption has been dominated by China. Chemrec, a Sweden based company has stared a new bio-based DME manufacturing facility. DME has been emerged as a potential alternative traditional resources of fuels.DME is most predominantly used in diesel engine as an alternative fuel. Growing demand for energy across the world is expected to be the major growth engine for DME market. To reduce the dependence on increased consumption of natural resource DME being ecofriendly in nature can be intensively used by automobile industries. DME can also be used to solve environmental conservation problem.
Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/toc/176543
Leading automobile industry giants such as Renault and Volvo have developed DME based fuel engine for buses. Major restraint of this market is developing process technologies being used. Due to lower viscocity and lubricity than diesel DME needs purpose built fuel injection systems. Hence very few vehicle test have being performed on DME based fuel engine. The durability and performance of DME fuel injection systems is major concern for the end users and is expected to be the major restraining force for DME market. Design of fuel injection system for DME is problematic due to problems created by chemical properties .Hence future work would include development of electronic fuel injection system for DME. One of the major hurdle for DME as transportation fuel is cost involved in investment and setup of distribution infrastructure.
Some of the major companies that develop DME as alternative to transportation fuel are Haldor Topsoe, Amoco, Aveflor, Toyo Engineering Corporation, Jiutai Energy (Zhangjiagang) Co., Ltd.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
• North America
• Asia Pacific
• Europe
• Rest of the World
This report provides comprehensive analysis of
• Market growth drivers
• Factors limiting market growth
• Current market trends
• Market structure
• Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
About Us
MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
Blog: http://mrrfocuseconomics.blogspot.com/
Michell Thoras, Market Research Reports, http://www.marketresearchreports.biz/, +1 (518) 618-1030, [email protected]
Share this article